Form D · Pharmaceuticals
Edge Therapeutics, Inc.
Berkeley Heights, NJ · CIK 0001472091
Offering snapshot reported Apr 9, 2015 · SEC filing
- Reported sold
- $56M Offering amount: $56M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 6, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 9, 2015 | Initial | $55,999,978 | No comparison | 19 | SEC filing |
| Nov 13, 2014 | Initial | $7,937,236 | No comparison | 104 | SEC filing |
| Mar 25, 2013 | Initial | $6,673,405 | No comparison | 52 | SEC filing |
| Sep 17, 2012 | Initial | $118,500 | No comparison | 2 | SEC filing |
| Jun 24, 2011 | Initial | $219,500 | No comparison | 5 | SEC filing |
| Nov 8, 2010 | Amendment | $634,500 | $134,500vs Sep 16, 2009 | 16 | SEC filing |
| Sep 16, 2009 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $3.3M
- Form D file number
- 021-237569
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Maxim Group, LLC | 120708 | |
| Leerink Partners LLC | 39011 | |
| Credit Suisse Securities (USA) LLC | 816 |
Source: Form D, filed Apr 9, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sol J. Barer | Director |
| Isaac Blech | Director |
| Leuthner A. Brian | Director, Executive |
| Kurt Conti | Director |
| Andrew Einhorn | Executive |
| Herbert J. Faleck | Executive |
| Priya Jambhekar | Executive |
| Brian A. Leuthner | Director, Executive |
| James J. Loughlin | Director |
| R. Loch Macdonald | Director, Executive, Promoter |
| Robert Loch Macdonald | Director, Executive |
| Bert Marchio | Executive, Promoter |
| Albert N. Marchio Ii | Executive |
| R Loch Mc Donald | Director, Executive, Promoter |
| Carl J. Soranno | Executive |
| Carl Sorrano | Director, Promoter |
| Robert Spiegel | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
200 Connell Drive, Suite 1600
Berkeley Heights, NJ, 07922
Berkeley Heights, NJ, 07922